Argentina Analysis

Pages

Industry Trend Analysis - Government Postpones Drug Price Cuts - APR 2014

The Argentine government's intervention in pharmaceutical pricing, particularly repeated price freezes, is both heavy handed and apparently open-ended. We have previously highlighted Argentina's highly challenging environment for pharmaceutical companies,, due to the anticipated future currency devaluation, high inflation and nationalisation approaches.[1]

READ FULL ARTICLE

Industry Trend Analysis - CAB To Promote Investments In Biotechnology - MAR 2014

Argentina's biotechnology sector has become relatively competitive due to low-cost operations, high quality professionals, export-oriented policies, downsizing by multinationals and the expanding domestic market. More PPPs will boost the local industry to develop technology and production capabilities along the value chain, as Argentina lacks sufficient commercial funding and market mechanisms...

READ FULL ARTICLE

Pages